Publication Name	World Journal of Clinical Cases
Manuscript ID	74437
Country	China

Received	2021-12-23 11:16
Peer-Review Started	2021-12-23 11:16
To Make the First Decision
Return for Revision	2022-01-25 18:29
Revised	2022-02-21 03:00
Second Decision	2022-03-15 05:54
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2022-03-16 14:42
Articles in Press	2022-03-16 14:42
Publication Fee Transferred
Edit the Manuscript by Language Editor	2022-03-11 17:38
Typeset the Manuscript	2022-04-08 06:21
Publish the Manuscript Online	2022-05-13 08:46

ISSN	2307-8960 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Hematology
Manuscript Type	Case Report
Article Title	Development of plasma cell dyscrasias in a patient with chronic myeloid leukemia: A case report
Manuscript Source	Unsolicited Manuscript
All Author List	Na Zhang, Ting-De Jiang and Shu-Hua Yi
ORCID	Author(s) ORCID Number Na Zhang http://orcid.org/0000-0001-8028-7643 Ting-De Jiang http://orcid.org/0000-0002-2023-2891 Shu-Hua Yi http://orcid.org/0000-0002-2041-8776
Funding Agency and Grant Number
Corresponding Author	Shu-Hua Yi, MD, Attending Doctor, Hematology Hospital of the Institute of Hematology, Chinese Academy of Medical Sciences, No. 288 Nanjing Road, Tianjin 300020, China. 3378465425@qq.com
Key Words	Chronic myeloid leukemia; Plasma cell dyscrasias; Multiple myeloma; Tyrosine kinase inhibitor; Translocation; Case report
Core Tip	Here we describe a patient with chronic myeloid leukemia complicated with plasma cell dyscrasias receiving dasatinib. He developed monoclonal gammopathy of undetermined significance that progressed to smoldering multiple myeloma and eventually to multiple myeloma. This case highlights that gene translocation may contribute to initiating and sustaining clonal proliferation. Tyrosine kinase inhibitors and cytogenetic change may lead to the progression.
Publish Date	2022-05-13 08:46
Citation	Zhang N, Jiang TD, Yi SH. Development of plasma cell dyscrasias in a patient with chronic myeloid leukemia: A case report. World J Clin Cases 2022; 10(14): 4698-4703
URL	https://www.wjgnet.com/2307-8960/full/v10/i14/4698.htm
DOI	https://dx.doi.org/10.12998/wjcc.v10.i14.4698

Full Article (PDF)	WJCC-10-4698.pdf
Full Article (Word)	WJCC-10-4698.docx
Manuscript File	74437_Auto_Edited-JLW-Filipodia.docx
Answering Reviewers	74437-Answering reviewers.pdf
Audio Core Tip	74437-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	74437-Conflict-of-interest statement.pdf
Copyright License Agreement	74437-Copyright license agreement.pdf
Signed Consent for Treatment Form(s) or Document(s)	74437-Informed consent statement.pdf
Non-Native Speakers of English Editing Certificate	74437-Language certificate.pdf
Peer-review Report	74437-Peer-review(s).pdf
Scientific Editor Work List	74437-Scientific editor work list.pdf
CrossCheck Report	74437-CrossCheck report.pdf